Literature DB >> 16079286

Dynein light chain rp3 acts as a nuclear matrix-associated transcriptional modulator in a dynein-independent pathway.

Ting-Yu Yeh1, Jen-Zen Chuang, Ching-Hwa Sung.   

Abstract

Cytoplasmic dynein is a motor protein complex involved in microtubule-based cargo movement. Previous biochemical evidence suggests that dynein light chain subunits also exist outside the dynein complex. Here we show that the dynein light chain rp3 is present in both the cytoplasm and the nucleus. Nuclear rp3 binds to and assembles with the transcription factor SATB1 at nuclear matrix-associated structures. Dynein intermediate chain was also detected in the nucleus, but it was dispensable for the rp3-SATB1 interaction. SATB1 facilitates the nuclear localization of rp3, whereas rp3 and dynein motor activity are not essential for nuclear accumulation of SATB1. The nuclear rp3-SATB1 protein complex is assembled with a DNA element of the matrix attachment region of the Bcl2 gene. Finally, rp3 is involved in SATB1-mediated gene repression of Bcl2. Our data provide evidence that dynein subunit rp3 has functions independent of the dynein motor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079286     DOI: 10.1242/jcs.02472

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

Review 1.  Unconventional functions of microtubule motors.

Authors:  Virgil Muresan; Zoia Muresan
Journal:  Arch Biochem Biophys       Date:  2012-01-28       Impact factor: 4.013

2.  Regulatory dissociation of Tctex-1 light chain from dynein complex is essential for the apical delivery of rhodopsin.

Authors:  Ting-Yu Yeh; Diego Peretti; Jen-Zen Chuang; Enrique Rodriguez-Boulan; Ching-Hwa Sung
Journal:  Traffic       Date:  2006-09-01       Impact factor: 6.215

3.  Structural and thermodynamic characterization of a cytoplasmic dynein light chain-intermediate chain complex.

Authors:  John C Williams; Petra L Roulhac; Anindya G Roy; Richard B Vallee; Michael C Fitzgerald; Wayne A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

4.  Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.

Authors:  Patricia M Day; Cynthia D Thompson; Rachel M Schowalter; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

5.  hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.

Authors:  Jason R Dobson; Hanna Taipaleenmäki; Yu-Jie Hu; Deli Hong; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian; Jitesh Pratap
Journal:  Cancer Cell Int       Date:  2014-08-02       Impact factor: 5.722

6.  Structure based function-annotation of hypothetical protein MGG_01005 from Magnaporthe oryzae reveals it is the dynein light chain orthologue of dynlt1/3.

Authors:  Guorui Li; Jinguang Huang; Jun Yang; Dan He; Chao Wang; Xiaoxuan Qi; Ian A Taylor; Junfeng Liu; You-Liang Peng
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

7.  Effects of dynein light chain Tctex-type 3 on the biological behavior of ovarian cancer.

Authors:  Lulu Zhou; Miaomiao Ye; Fang Xue; Ermei Lu; Lu-Zhe Sun; Xueqiong Zhu
Journal:  Cancer Manag Res       Date:  2019-07-01       Impact factor: 3.989

8.  A role for Dynlt3 in melanosome movement, distribution, acidity and transfer.

Authors:  Zackie Aktary; Alejandro Conde-Perez; Florian Rambow; Mathilde Di Marco; François Amblard; Ilse Hurbain; Graça Raposo; Cédric Delevoye; Sylvie Coscoy; Lionel Larue
Journal:  Commun Biol       Date:  2021-03-26

9.  Upregulation of SATB1 is associated with the development and progression of glioma.

Authors:  Sheng-Hua Chu; Yan-Bin Ma; Dong-Fu Feng; Hong Zhang; Zhi-An Zhu; Zhi-Qiang Li; Pu-Cha Jiang
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

10.  Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.

Authors:  Nayan J Sarma; Nabeel R Yaseen
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.